Single‐center experience of the Crohn's disease exclusion diet in the United States: A retrospective study
Nutrition in Clinical Practice · 2026-08 · 41 (4) · 1132-1143
DOI: 10.1002/ncp.70122 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nutrition in Clinical Practice, online erschienen am 15.04.2026. Verfasst von Mayah Greenfield und 5 weiteren Autor:innen. Beteiligte Einrichtung: Robert Louis Katz & Manne Research Institute Summer Scholars Program, Northwestern Medicine, Chicago, Illinois, USA. Hauptthemen laut MEDLINE: Crohn Disease. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
The Crohn's Disease Exclusion Diet (CDED) offers a dietary means of inducing and maintaining remission for patients with Crohn's disease (CD). Descriptions of efficacy have emerged primarily from Israel, Europe, and Canada. Here, we offer real‐world experience, from a tertiary care center in the United States.
Methods
We conducted a retrospective chart review of patients receiving education on the CDED and those adopting the diet. Demographics, medication exposure, disease‐related complications, and reported side effects were collected. Corticosteroid‐free clinical remission (SF‐CR) was measured at weeks 6, 12, and 24 via the pediatric Crohn's Disease Activity Index (PCDAI). Biomarkers were collected at baseline and while on the diet.
Results
Only 8% ( n = 32) of children with CD had met with a dietitian regarding the CDED. Of those, 75% ( n = 24) adopted the diet. A statistically significant change in PCDAI from baseline to weeks 6, 12, and 24 ( χ 2 (3) = 9.61, P = 0.02) was observed. At 24 weeks, SF‐CR was achieved in 9/11 subjects who remained on the diet, with a significant decrease in fecal calprotectin (Wilcoxon signed‐rank test p < 0.01, 95% CI). In seven subjects with pre/post endoscopic assessment, endoscopic response was demonstrated in 71%. Side effects were mild and included increased abdominal pain, diarrhea, and weight loss (37.5%, n = 9).
Conclusion
In this single‐center experience of children with mild to moderate CD who adopted the CDED, adherence was a challenge. However, for those who were able to sustain the diet, the CDED offered a safe and effective means of clinical remission.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Robert Louis Katz & Manne Research Institute Summer Scholars Program, Northwestern Medicine, Chicago, Illinois, USA.
- Department of Clinical Nutrition, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, USA.
- Stanley Manne Children's Research Institute, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, USA.
- Division of Gastroenterology, Hepatology & Nutrition, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, USA.
- Department of Pediatrics, Feinberg School of Medicine, Chicago, Illinois, USA.
ORCID-Profile: Joseph Runde
Zitieren
APA
Greenfield, M., Salozzo, C., Chen, W., Strople, J., Brown, J., & Runde, J. (2026). Single‐center experience of the Crohn's disease exclusion diet in the United States: A retrospective study. Nutrition in Clinical Practice, 41(4), 1132-1143. https://doi.org/10.1002/ncp.70122
Vancouver
Greenfield M, Salozzo C, Chen W, Strople J, Brown J, Runde J. Single‐center experience of the Crohn's disease exclusion diet in the United States: A retrospective study. Nutrition in Clinical Practice. 2026;41(4):1132-1143. doi:10.1002/ncp.70122
BibTeX
@article{Greenfield2026,
author = {Greenfield, Mayah and Salozzo, Caroline and Chen, Wenya and Strople, Jennifer and Brown, Jeffrey and Runde, Joseph},
title = {Single‐center experience of the Crohn's disease exclusion diet in the United States: A retrospective study},
journal = {Nutrition in Clinical Practice},
year = {2026},
volume = {41},
number = {4},
pages = {1132--1143},
doi = {10.1002/ncp.70122}
}
EUVIMED